129 related articles for article (PubMed ID: 29452771)
1. Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma.
Milgrom SA; Pinnix CC; Chi TL; Vu TH; Gunther JR; Sheu T; Fowler N; Westin JR; Nastoupil LJ; Oki Y; Fayad LE; Neelapu S; Rodriguez MA; Hagemeister FB; Fanale MA; Lee HJ; Hosing C; Ahmed S; Nieto Y; Shpall EJ; Dabaja BS
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1146-1154. PubMed ID: 29452771
[TBL] [Abstract][Full Text] [Related]
2. Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab.
Papageorgiou SG; Diamantopoulos P; Levidou G; Angelopoulou MK; Economopoulou P; Efthimiou A; Constantinou N; Katsigiannis A; Korkolopoulou P; Pappa V; Economopoulou C; Georgiou G; Dimou M; Tsirigotis P; Kyrtsonis MC; Kotsianidis I; Kalpadakis C; Dimopoulos MA; Beris P; Meletis J; Pangalis GA; Dervenoulas J; Panayiotidis P; Vassilakopoulos TP
Hematol Oncol; 2013 Mar; 31(1):10-7. PubMed ID: 22610484
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma.
Ho JC; Dabaja BS; Milgrom SA; Smith GL; Reddy JP; Mazloom A; Young KH; Deng L; Medeiros LJ; Dong W; Allen PK; Andraos TY; Fowler NH; Nastoupil LJ; Oki Y; Fayad LE; Turturro F; Neelapu SS; Westin J; Hagemeister FB; Rodriguez MA; Pinnix CC
Leuk Lymphoma; 2017 Dec; 58(12):2833-2844. PubMed ID: 28482717
[TBL] [Abstract][Full Text] [Related]
4. Focal radiation therapy for limited brain metastases is associated with high rates of local control and low subsequent whole brain radiation therapy.
Or M; Jayamanne D; Guo L; Stevens M; Parkinson J; Cook R; Little N; Back M
ANZ J Surg; 2019 Apr; 89(4):418-422. PubMed ID: 30836451
[TBL] [Abstract][Full Text] [Related]
5. Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma.
Mannisto S; Vähämurto P; Pollari M; Clausen MR; Jyrkkiö S; Kellokumpu-Lehtinen PL; Kovanen P; Karjalainen-Lindsberg ML; d'Amore F; Leppä S
Eur J Cancer; 2019 Jul; 115():27-36. PubMed ID: 31082690
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy.
Al Feghali KA; Fang P; Gule-Monroe M; Milgrom S; Khoury JD; Gunther JR; Sheu T; Nair R; Ahmed S; Steiner R; Strati P; Shpall EJ; Nieto YL; Hosing C; Nastoupil LJ; Westin JR; Neelapu SS; Fowler N; Flowers C; Pinnix CC; Dabaja BS
Leuk Lymphoma; 2021 Oct; 62(10):2400-2407. PubMed ID: 33942701
[TBL] [Abstract][Full Text] [Related]
7. Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.
Ng AK; Yahalom J; Goda JS; Constine LS; Pinnix CC; Kelsey CR; Hoppe B; Oguchi M; Suh CO; Wirth A; Qi S; Davies A; Moskowitz CH; Laskar S; Li Y; Mauch PM; Specht L; Illidge T
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):652-669. PubMed ID: 29413279
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
Ferreri AJ; Reni M; Dell'Oro S; Ciceri F; Bernardi M; Camba L; Ponzoni M; Terreni MR; Tomirotti M; Spina M; Villa E
Oncology; 2001; 60(2):134-40. PubMed ID: 11244328
[TBL] [Abstract][Full Text] [Related]
9. Role of Salvage Radiation Treatment of Relapses in Relapsed/Refractory Diffuse Large B Cell Lymphoma Post-Autologous Stem Cell Transplant.
Ladbury C; Kambhampati S; Othman T; Hao C; Chen L; Wong J; Cao T; Herrera A; Mei M; Dandapani S
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(3):594-601. PubMed ID: 35176414
[TBL] [Abstract][Full Text] [Related]
10. High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma.
Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E
Leuk Lymphoma; 2006 Aug; 47(8):1545-52. PubMed ID: 16966265
[TBL] [Abstract][Full Text] [Related]
11. Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy.
Yoder AK; Gunther JR; Milgrom SA; Mirkovic D; Nastoupil L; Neelapu S; Fanale M; Fowler N; Westin J; Lee HJ; Rodriguez MA; Iyer SP; Fayad L; Nieto YL; Hosing C; Ahmed S; Medeiros LJ; Khoury JD; Garg N; Amini B; Dabaja BS; Pinnix CC
Clin Lymphoma Myeloma Leuk; 2019 Jan; 19(1):e51-e61. PubMed ID: 30360985
[TBL] [Abstract][Full Text] [Related]
12. Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era.
Hiniker SM; Pollom EL; Khodadoust MS; Kozak MM; Xu G; Quon A; Advani RH; Hoppe RT
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):99-106. PubMed ID: 25863757
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
14. Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.
Pinnix CC; Dabaja B; Ahmed MA; Chuang HH; Costelloe C; Wogan CF; Reed V; Romaguera JE; Neelapu S; Oki Y; Rodriguez MA; Fayad L; Hagemeister FB; Nastoupil L; Turturro F; Fowler N; Fanale MA; Nieto Y; Khouri IF; Ahmed S; Medeiros LJ; Davis RE; Westin J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):113-21. PubMed ID: 25863759
[TBL] [Abstract][Full Text] [Related]
15. Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era.
Biswas T; Dhakal S; Chen R; Hyrien O; Bernstein S; Friedberg JW; Fisher RI; Liesveld J; Phillips G; Constine LS
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):79-85. PubMed ID: 19647953
[TBL] [Abstract][Full Text] [Related]
16. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
[TBL] [Abstract][Full Text] [Related]
17. Impact of Radiation Therapy After High Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients With Relapsed/Refractory Lymphomas: A Single Center Experience.
Osmani AH; Khafaga Y; Rauf MS; Maghfoor I; Akhtar S
Clin Lymphoma Myeloma Leuk; 2022 Mar; 22(3):e149-e160. PubMed ID: 34627735
[TBL] [Abstract][Full Text] [Related]
18. Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation.
Kambhampati S; Hunter B; Varnavski A; Fakhri B; Kaplan L; Ai WZ; Pampaloni M; Huang CY; Martin T; Damon L; Andreadis CB
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):246-256.e2. PubMed ID: 33288485
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Transplant-Eligible Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Salvage Chemotherapy: The Gustave Roussy Experience.
Rassy E; Danu A; Ibrahim T; Lazarovici J; Ghez D; Michot JM; Arfi-Rouche J; Rossignol J; Vergé V; Dartigues P; Ribrag V
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e373-e380. PubMed ID: 33277224
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation.
Morschhauser F; Illidge T; Huglo D; Martinelli G; Paganelli G; Zinzani PL; Rule S; Liberati AM; Milpied N; Hess G; Stein H; Kalmus J; Marcus R
Blood; 2007 Jul; 110(1):54-8. PubMed ID: 17387223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]